BEIJING and SYDNEY, April 30 (Bernama-GLOBE NEWSWIRE) — Guangzhou Link Health Pharma Co., Ltd. (Link Health) and George Clinical Pty Ltd (George Clinical) have signed a term sheet to enter into a strategic agreement to establish an independent joint venture clinical development company called Link-George Clinical Research Co., Ltd (Link-George). Link-George will deliver clinical trials for Link Health and related companies that it has entered into licensing deals with. The plan is for Link-George to launch six clinical trials in 2021 and this is expected to grow as Link Health’s in-licensed portfolio expands. Link-George will be majority owned by Link Health and operationally led by George Clinical with a board that comprises representatives from both Link Health and George Clinical.
“We are very excited to enter into this joint venture with Link Health as part of a novel platform providing a one-stop service for in-licensing, clinical development, marketing authorization and commercialization. This will enable both companies to further optimize the tremendous growth in the pharmaceutical industry in China and in so doing, help to advance clinical research in this region,” stated George Clinical Chief Executive Officer James Cheong.